DETAIL

DETAIL INFORMATION

为什么说Ⅱ型糖尿病患者应广泛使用他汀类药物？

Published:

2018-08-06

Source:

Author:

美国内科医师会建议，Ⅱ型糖尿病应广泛使用他汀类降脂药以预防心血管病的发生。要认识到控制心血管病高危因素（特别是高血压与胆固醇浓度）与控制血糖浓度同样重要。糖尿病的不良预后是微血管或大血管病的并发症，前者有视网膜病和肾病，后者有冠状动脉病、外周血管和脑血管病。一些研究证实80%糖尿病患者将死于大血管病，因此，学会提出以下建议：（1）所有确诊为冠状动脉疾病和Ⅱ型糖尿病的成人患者应接受他汀类药物作为心血

       美国内科医师会建议，Ⅱ型糖尿病应广泛使用他汀类降脂药以预防心血管病的发生。要认识到控制心血管病高危因素（特别是高血压与胆固醇浓度）与控制血糖浓度同样重要。糖尿病的不良预后是微血管或大血管病的并发症，前者有视网膜病和肾病，后者有冠状动脉病、外周血管和脑血管病。一些研究证实80%糖尿病患者将死于大血管病，因此，学会提出以下建议：（1）所有确诊为冠状动脉疾病和Ⅱ型糖尿病的成人患者应接受他汀类药物作为心血管病的二级预防；（2）所有Ⅱ型糖尿病与其他心血管病高危因素（包括高血压、吸烟、左心室肥厚和年龄大于55岁）患者应接受他汀作为大血管病的一级预防；（3）已接受他汀类的患者至少应服中等剂量，即阿伐他汀20㎎，一天一次，洛伐他汀40㎎，一天一次，普伐他汀均

Back

不同类药物的最佳服用时间

Relative news

Warm congratulations to Fengyuan Pharmaceutical on the successful convening of the 2013 annual work summary and commendation conference

On January 25, 2014, Fengyuan Pharmaceutical held the 2013 annual work summary and commendation meeting in the multi-functional hall on the sixth floor of the headquarters. The headquarters executives, managers and employees of various functional departments, the leadership team of subsidiaries and advanced individuals participated in the meeting. Meeting. The meeting first summarized the work in 2013 and looked forward to 2014. At the same time, advanced individuals and groups with outstanding performance were commended. After the meeting, the company arranged a wonderful "2014 Welcome Party" and a rich dinner.

2022-06-30

Revisiting the history, cherishing the present, and looking forward to the future---remember the July 1 Party Member Activity Conference of Fengyuan Pharmaceutical Party Branch

At 15:00 on July 1, 2015, the party committee of Fengyuan Pharmaceutical held a party member activity meeting for the 94th anniversary of the founding of the party in the company's No. 1 conference room. The conference was presided over by Ru Tianle, Secretary of the Party Committee of the company. The event was divided into two main agendas: the swearing-in ceremony of new party members and the training of party history class. All party members stood up and sang "The Internationale" to kick off the event. The first item of the agenda, first of all, Ru Tianle, secretary of the party committee, read out the list of prospective party members and led three new party members to take the oath of joining the party facing the national flag. The old party member representative Xiao Guosong made a speech, mainly reporting to the participating party members his experience in work and life as an old party member, advocating

2022-06-30

Practical training in corporate strategic thinking and strategy formulation

From April 12th to 13th, 2015, the company organized the training of "Enterprise Strategic Thinking and Strategy Formulation Practice", and the middle and senior managers of the company and the senior managers of subsidiaries participated in the training. The following are training pictures:

2022-06-30

Warmly welcome the leaders of Wuhu City to visit Wuwei Pharmaceutical Factory for inspection and guidance

On March 3, 2015, Wuhu Municipal Party Committee Secretary Gao Dengbang, Mayor Pan Zhaohui, Deputy Mayor Lin Xuwen and some other members of the four major groups, the principals of various counties and districts and other government leaders visited Fengyuan Pharmaceutical Wuwei Pharmaceutical Factory Fudu New Plant for inspection Guidance, the company's general manager Gao Ji, Wuwei pharmaceutical factory director Hu Baowen accompanied the whole process. First of all, the company's general manager, on behalf of all the company's employees, extended a warm welcome to all the leaders, and made a detailed report on Anhui Fengyuan Pharmaceutical Co., Ltd., the fundraising project of Wuwei Pharmaceutical Factory, and the product planning of Wuwei Pharmaceutical Factory in the next five years. While providing the physical samples, he introduced the Wuwei Pharmaceutical Factory to the inspection leaders.

2022-06-30

图片名称

86-0551-64846100

图片名称

127841476@qq.com

大兴

CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd  Powered by：www.300.cn  SEO

京ICP备10002622号-38